DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

LinksClose Window

References

clinicaltrials.gov.
NCT02513394, PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer (PALLAS). NIH U.S. National Library of Medicine, 2015.
Accessed November 17, 2018 at:
https://clinicaltrials.gov/ct2/show/NCT02513394

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.